2020, Number 4
<< Back Next >>
Acta de Otorrinolaringología CCC 2020; 48 (4)
Olfactory and taste disorders associated with SARS-CoV-2 infection: a review
Alfaro-Arias LI, Ballesteros-Rodríguez LA, Posada-Álvarez ME, Martínez-Estrada A
Language: Spanish
References: 24
Page: 316-321
PDF size: 127.96 Kb.
ABSTRACT
Chemical senses such as smell and taste are decisive in the quality of life and performance
of some tasks of daily life. They are senses that play a fundamental role in
everyday life and in interpersonal relationships. There are multiple pathologies that
alter these senses, including viral infection diseases. Over the last few months, it has
been shown that the virus responsible for the current pandemic (SARS-CoV-2) can
generate changes in smell and taste secondary to its infection, these alterations being
sometimes the first demonstrations. This review seeks to compile the information
found in the medical literature and conclude the importance of taking these alterations
into account when examining a patient and generating an alert regarding the
possible isolation and / or treatment measures for these patients.
REFERENCES
Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirusdisease 2019 in China. N Engl J Med. 2020;382(18):1708–20.
Villalba NL, Maouche Y, Ortiz MBA, et al. Anosmia andDysgeusia in the Absence of Other Respiratory Diseases:Should COVID-19 Infection Be Considered? Eur J case reportsIntern Med. 2020;7(4):001641.
Park SE. Epidemiology, virology, and clinical features of severeacute respiratory syndrome coronavirus 2 (SARS-CoV-2;coronavirus disease-19). Pediatr Infect Vaccine. 2020;27(1):1–10.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors formortality of adult inpatients with COVID-19 in Wuhan, China: aretrospective cohort study. Lancet. 2020;395(10229):1054–62.
Allis TJ, Leopold DA. Smell and Taste Disorders. Facial PlastSurg Clin North Am. 2012;20(1):93–111.
Miwa T, Ikeda K, Ishibashi T, et al. Clinical practice guidelinesfor the management of olfactory dysfunction — Secondarypublication. Auris Nasus Larynx. 2019;46(5):653–62.
Imamura F, Hasegawa-Ishii S. Environmental Toxicants-Induced Immune Responses in the Olfactory Mucosa. FrontImmunol. 2016;7:475.
Lop Gros J, Iglesias Coma M, González Farré M, et al.Alteraciones del olfato en la COVID-19, revisión de la evidenciae implicaciones en el manejo de la pandemia [Olfactorydysfunction in COVID-19, a review of the evidence andimplications for pandemic management]. Acta OtorrinolaringolEsp. 2020;71(6):379-385.
Yan CH, Faraji F, Prajapati DP, et al. Self-reported olfactoryloss associates with outpatient clinical course in COVID-19. IntForum Allergy Rhinol. 2020;10(7):821–31.
Meng X, Deng Y, Dai Z, et al. COVID-19 and anosmia: Areview based on up-to-date knowledge. Am J Otolaryngol -Head Neck Med Surg. 2020;41(5):102581.
Bénézit F, Le Turnier P, Declerck C, et al. Utility of hyposmiaand hypogeusia for the diagnosis of COVID-19. Lancet InfectDis. 2020;3099(20):19–20.
Moein ST, Hashemian SMR, Mansourafshar B, et al. Smelldysfunction: a biomarker for COVID-19. Int Forum AllergyRhinol. 2020;10(8):944–50.
Xydakis MS, Dehgani-Mobaraki P, Holbrook EH, et al. Smelland taste dysfunction in patients with COVID-19. Lancet InfectDis. 2020;3099(20):30293.
Karimi-Galougahi M, Raad N, Mikaniki N. Anosmia andthe Need for COVID-19 Screening during the Pandemic.Otolaryngol Head Neck Surg. 2020;163(1):96-97.
Karimi-Galougahi M, Yousefi-Koma A, Bakhshayeshkaram M,Raad N, Haseli S. 18FDG PET/CT Scan Reveals HypoactiveOrbitofrontal Cortex in Anosmia of COVID-19. Acad Radiol.2020;27(7):1042-1043.
Lee Y, Min P, Lee S, et al. Prevalence and Duration of AcuteLoss of Smell or Taste in COVID-19 Patients. J Korean MedSci. 2020;35(18):e174.
Giacomelli A, Pezzati L, Conti F, et al. Self-reported Olfactoryand Taste Disorders in Patients With Severe Acute RespiratoryCoronavirus 2 Infection: A Cross-sectional Study. Clin InfectDis. 2020;71(15):889-890.
Wee LE, Chan YFZ, Teo NWY, et al. The role of self-reportedolfactory and gustatory dysfunction as a screening criterionfor suspected COVID-19. Eur Arch Oto-Rhino-Laryngology.2020;(0123456789):20–1.
Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactoryand gustatory dysfunctions as a clinical presentation of mildto-moderate forms of the coronavirus disease (COVID-19): amulticenter European study. Eur Arch Oto-Rhino-Laryngology.
2020;277(8):2251–61.20. Beltrán-Corbellini, Chico-García JL, Martínez-Poles J, etal. Acute-onset smell and taste disorders in the context ofCOVID-19: a pilot multicentre polymerase chain reactionbased case–control study. Eur J Neurol. 2020;27(9):1738–41.
Eliezer M, Hautefort C, Hamel A-L, et al. Sudden and CompleteOlfactory Loss Function as a Possible Symptom ofCOVID-19.JAMA Otolaryngol - Head Neck Surg. 2020;92(6):E1–2.
Kaye R, Chang CWD, Kazahaya K, et al. COVID-19 AnosmiaReporting Tool: Initial Findings. Otolaryngol - Head Neck Surg(United States). 2020;163(1):132–4.
Hopkins C, Kumar N. Loss of sense of smell as markerof COVID-19 infection: joint statement from the BritishRhinological Society and ENT-UK. Entuk. 2020;1–2.
Doty RL. Treatments for smell and taste disorders: A criticalreview. Handb Clin Neurol. 2019;164:455–79.